Biosynthesis of toxic glutathione conjugates from halogenated alkenes

Toxicology Letters

Volumn 144, Issue 1, 2003, Pages 49-54

  Dekant, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Glutathione S conjugates; Haloalkenes; Kidney; Toxicity

Indexed keywords

ALKENE; CYSTEINE CONJUGATE; CYSTEINE CONJUGATE BETA LYASE; GLUTATHIONE; KETENE DERIVATIVE;

BIOSYNTHESIS; CHLORINATION; CONFERENCE PAPER; CONJUGATE; COVALENT BOND; GLUTATHIONE METABOLISM; HALOGENATION; KIDNEY; MACROMOLECULE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TOXICITY; TUBULAR DYSFUNCTION;

ALKENES; ANIMALS; BIOTRANSFORMATION; GLUTATHIONE; HUMANS; HYDROCARBONS, HALOGENATED;

EID: 0042661009     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00338-7     Document Type: Conference Paper

References (54)

1. Anders M.W. Bioactivation mechanisms and hepatocellular damage. Arias I.M., Jakoby W.B., Popper H., Schachter D., Shafritz D.A. The Liver: Biology and Pathology. second ed. 1988;389-400 Raven Press, Ltd, New York.
2. Anders M.W. Glutathione-dependent bioactivation of xenobiotics. FASEB J. 4:1991;87-92.
3. Anders M.W., Dekant W. Renal xenobiotic metabolism: role in bioactivation of nephrotoxic xenobiotics. Anders M.W., Dekant W., Henschler D., Oberleithner H., Silbernagl S. Renal Disposition and Nephrotoxicity of Xenobiotics. 1993;155-183 Academic Press, Inc, San Diego.
4. Anders M.W., Dekant W. Glutathione-dependent bioactivation of haloalkenes. Annu. Rev. Pharmacol. Toxicol. 38:1998;501-537.
5. Anders M.W., Dekant W., Henschler D., Oberleithner H., Silbernagl S. Renal Disposition and Nephrotoxicity of Xenobiotics. 1993;Academic Press, Inc, San Diego.
6. Anders M.W., Lash L.H., Dekant W., Elfarra A.A., Dohn D.R. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. Crit. Rev. Toxicol. 18:1988;311-342.
7. Boyland E., Chasseaud L.F. Role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis. Adv. Enzymol. 32:1969;173-177.
8. Commandeur J.N.M., Oostendorp R.A.J., Schoofs P.R., Xu B., Vermeulen N.P.E. Nephrotoxicity and hepatotoxicity of 1,1-dichloro-2,2-difluoroethylene in the rat. Biochem. Pharmacol. 36:1987;4229-4237.
9. Dekant W., Birner G., Werner M., Parker J. Glutathione conjugation of perchloroethene in subcellular fractions from rodent and human liver and kidney. Chem.-Biol. Interact. 116:1998;31-43.
10. Dekant W., Koob M., Henschler D. Metabolism of trichloroethene-in vivo and in vitro evidence for activation by glutathione conjugation. Chem.-Biol. Interact. 73:1990;89-101.
11. Dekant W., Martens G., Vamvakas S., Metzler M., Henschler D. Bioactivation of tetrachloroethylene - role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab. Dispos. 15:1987;702-709.
12. Dekant W., Metzler M., Henschler D. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem. Pharmacol. 33:1984;2021-2027.
13. Dekant W., Metzler M., Henschler D. Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. Biochem. Pharmacol. 35:1986;2455-2458.
14. Dekant W., Metzler M., Henschler D. Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene: bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity. J. Biochem. Toxicol. 1:1986;57-72.
15. Dekant W., Schrenk D., Vamvakas S., Henschler D. Metabolism of hexachloro-1,3-butadiene in mice: in vivo and in vitro evidence for activation by glutathione conjugation. Xenobiotica. 18:1988;803-816.
16. Dekant W., Vamvakas S. Glutathione-dependent bioactivation of xenobiotics. Xenobiotica. 23:1993;873-887.
17. Dekant W., Vamvakas S., Anders M.W. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate β-lyase. Drug Metab. Rev. 20:1989;43-83.
18. Dekant W., Vamvakas S., Henschler D., Anders M.W. Enzymatic conjugation of hexachloro-1,3-butadiene with glutathione: formation of 1-(glutathion-S-yl)-1,2,3,4,4-pentachlorobuta-1,3-diene and 1,4-bis(glutathion-S-yl)-1,2,3,4- tetrachlorobuta-1,3-diene. Drug Metab. Dispos. 16:1988;701-706.
19. Dohn D.R., Anders M.W. The enzymatic reaction of chlorotrifluoroethylene with glutathione. Biochem. Biophys. Res. Commun. 109:1982;1339-1345.
20. Green T., Dow J., Ellis M.K., Foster J.R., Odum J. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem.-Biol. Interact. 105:1997;99-117.
21. Hargus S.J., Fitzsimmons M.E., Aniya Y., Anders M.W. Stereochemistry of the microsomal glutathione S-transferase catalyzed addition of glutathione to chlorotrifluoroethene. Biochemistry. 30:1991;717-721.
22. Ishmael J., Pratt I., Lock E.A. Necrosis of the pars recta (S3 segment) of the rat kidney produced by hexachloro-1:3-butadiene. J. Pathol. 138:1982;99-113.
23. Jin L., Davis M.R., Kharasch E.D., Doss G.A., Baillie T.A. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevofluorane. Chem. Res. Toxicol. 9:1996;555-561.
24. Jin L.X., Baillie T.A., Davis M.R., Kharasch E.D. Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate beta-lyase. Biochem. Biophys. Res. Com. 210:1995;498-506.
25. Kanhai W., Dekant W., Henschler D. Metabolism of the nephrotoxin dichloroacetylene by glutathione conjugation. Chem. Res. Toxicol. 2:1989;51-56.
26. Kanhai W., Koob M., Dekant W., Henschler D. Metabolism of 14C-dichloroethyne in rats. Xenobiotica. 21:1991;905-916.
27. Kharasch, E.D., Garton, K., Hankins, D. and Kilty, C., 1995. The role of glutathione and cysteine conjugates and renal cysteine conjugate β-lyase in compound A nephrotoxicity. Biotrin International Abstract.
28. Kharasch E.D., Thorning D., Garton K., Hankins K.C., Kilty C.G. Role of renal cysteine S-conjugate β-lyase in the mechanism of Compound A neprotoxicity in rats. Anesthesiology. 86:1997;160-171.
29. Kociba R.J., Keyes D.G., Jersey G.C., Ballard J.J., Dittenber D.A., Quast J.F., Wade L.E., Humiston C.G., Schwetz B.A. Results of a two year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38:1977;589-602.
30. Koob M., Dekant W. Metabolism of hexafluoropropene - evidence for bioactivation by glutathione conjugate formation in the kidney. Drug Metab. Dispos. 18:1990;911-916.
31. Lash L.H. Role of renal metabolism in risk to toxic chemicals. Environ. Health Perspect. 102:1994;75-79.
32. Lash L.H., Putt D.A., Brashear W.T., Abbas R., Parker J.C., Fisher J.W. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J. Toxicol. Environ. Health. 56:1999;1-21.
33. Lash L.H., Qian W., Putt D.A., Desai K., Elfarra A.A., Sicuri A.R., Parker J.C. Glutathione conjugation of perchloroethylene in rats and mice in vitro: sex-, species-, and tissue-dependent differences. Toxicol. Appl. Pharmacol. 150:1998;49-57.
34. Lash L.H., Qian W., Putt D.A., Jacobs K., Elfarra A.A., Krause R.J., Parker J.C. Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences. Drug Metab. Dispos. 26:1998;12-19.
35. Lash L.H., Xu Y.P., Elfarra A.A., Duescher R.J., Parker J.C. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Dispos. 23:1995;846-853.
36. Lock E.A. Mechanism of nephrotoxic action due to organohalogenated compounds. Toxicol. Lett. 46:1989;93-106.
37. Lock E.A. Responses of the kidney to toxic compounds. Ballantyne B., Marrs T., Turner P. General and Applied Toxicology. 1993;507-536 Macmillan Press, New York.
38. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263:1988;17205-17208.
39. Meister A. Commentary: on the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44:1992;1905-1915.
40. Monks T.J., Anders M.W., Dekant W., Stevens J.L., Lau S.S., van Bladeren P.J. Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol. 106:1990;1-19.
41. Monks T.J., Lau S.S. Toxicology of quinone-thioethers. Crit. Rev. Toxicol. 22:1992;243-270.
42. Monks T.J., Lau S.S. The pharmacology and toxicology of polyphenolic-glutathione conjugates. Annu. Rev. Pharmacol. Toxicol. 38:1998;229-255.
43. Nash J.A., King L.J., Lock E.A., Green T. The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol. Appl. Pharmacol. 73:1984;124-137.
44. NCI, 1986. Carcinogenesis bioassay of tetrachloroethylene. National Toxicology Program, National Cancer Institute, TR 232.
45. NCI, 1986. Carcinogenesis bioassay of trichloroethylene. National Toxicology Program, National Cancer Institute, TR 311.
46. Odum J., Green T. The metabolism and nephrotoxicity of tetrafluoroethylene in the rat. Toxicol. Appl. Pharmacol. 76:1984;306-318.
47. Oesch F., Wolf C.R. Properties of the microsomal and cytosolic glutathione transferases involved in hexachloro-1:3-butadiene conjugation. Biochem. Pharmacol. 38:1989;353-359.
48. Potter C.L., Gandolfi A.J., Nagle R., Clayton J.W. Effects of inhaled chlorotrifluoroethylene and hexafluoropropene on the rat kidney. Toxicol. Appl. Pharmacol. 59:1981;431-440.
49. Reichert D., Ewald D., Henschler D. Generation and inhalation toxicity of dichloroacetylene. Fd. Cosmet. Toxicol. 13:1975;511-515.
50. Reichert D., Schuetz S. Mercapturic acid formation is an activation and intermediary step in the metabolism of hexachlorobutadiene. Biochem. Pharmacol. 35:1986;1271-1275.
51. Vamvakas S., Herkenhoff M., Dekant W., Henschler D. Mutagenicity of tetrachloroethylene in the Ames-test - metabolic activation by conjugation with glutathione. J. Biochem. Toxicol. 4:1989;21-27.
52. Vamvakas S., Kremling E., Dekant W. Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation. Biochem. Pharmacol. 38:1989;2297-2304.
53. Wallin A., Gerdes R.G., Morgenstern R., Jones T.W., Ormstad K. Features of microsomal and cytosolic glutathione conjugation of hexachlorobutadiene in rat liver. Chem.-Biol. Interactions. 68:1988;1-11.
54. Wolf C.R., Berry P.N., Nash J.A., Green T., Lock E.A. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity. J. Pharmacol. Exp. Ther. 228:1984;202-208.